Vetstem
1 known investors
VETSTEM develops regenerative cell therapies based on multipotent mesenchymal stem cells (MSCs) and high-bioavailability pharmaceutical products for treating diseases in pets. The company operates in veterinary biotech, applying molecular-cell technologies and pharmaceutical chemistry to animal health.
Investors · 1
Frequently asked questions
- What does Vetstem do?
- VETSTEM develops regenerative cell therapies based on multipotent mesenchymal stem cells (MSCs) and high-bioavailability pharmaceutical products for treating diseases in pets. The company operates in veterinary biotech, applying molecular-cell technologies and pharmaceutical chemistry to animal health.
- Who are Vetstem's investors?
- Vetstem's investors include Moscow Venture Fund (formerly Moscow Seed Fund).